- Design
- Five systematic reviews and meta-analyses (GRADE)
- Population
- Children with UTI, suspected UTI, reflux or bladder-bowel dysfunction (60 studies)
- Primary outcome
- Recurrence, scarring, adverse events, resistant infection
- Effect
- ≤7 days and oral therapy not worse; prophylaxis no clear benefit, more resistance (low certainty)
The technical report behind the updated American Academy of Pediatrics UTI guideline, in Pediatrics (1 October), ran five systematic reviews across 60 studies. Certainty was low to very low throughout, but the direction was consistent.
Seven days or fewer of antibiotics may not raise the risk of recurrence and likely causes fewer side-effects. Oral treatment may work as well as intravenous or intravenous-then-oral, without admission. Continuous prophylaxis in children with vesicoureteric reflux or bladder-bowel dysfunction may not reduce breakthrough infection or renal scarring, and may increase resistant infections. Evaluation within 72 hours of symptoms may be associated with less scarring.
Together this points to faster assessment, shorter oral courses and far less prophylaxis. Check how your national guidance and the AAP guideline itself phrase each recommendation before changing protocols. Resistance patterns in India differ, so choose the oral agent on local susceptibility data.
- Consider seven days or fewer of antibiotics for uncomplicated UTI
- Treat orally when the child can take and keep down medicines
- Reconsider routine prophylaxis in reflux or bladder-bowel dysfunction; it may raise resistance
- See children with suspected UTI promptly, ideally within 72 hours of symptoms
- Choose the oral agent on local resistance data
Why it matters
Long intravenous courses and prolonged prophylaxis add harm and resistance without clear benefit.
Don't overread it
Certainty was low to very low — these are directions supported by evidence, not proof.
The statistics, in plain English
Low certainty means further research could well change the estimates. The value lies in the absence of evidence that longer, intravenous or prophylactic treatment does better.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for paediatrics, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free